What topics does this cannabis study cover?

This study covers research on: CBD, Inflammation, Neuroprotection.

Where was this research published?

Published in JBMR plus on February 1, 2026.

CBD Falls Short in Preventing Postmenopausal Bone Loss

Q: What did this research study find?

**CBD did not prevent bone density decline** in ovariectomized rat model

Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats.

JBMR plus • February 1, 2026 • Relevant

🤖

AI Summary

In a detailed study examining cannabidiol's (CBD) potential for bone health, researchers investigated its effects on bone loss in postmenopausal conditions using an ovariectomized rat model. The research focused on understanding whether CBD could provide protective benefits for bone metabolism during estrogen deficiency, a critical concern for postmenopausal women at risk of osteoporosis.

The findings revealed that CBD at 5 mg/kg/day did not prevent bone density decline in the experimental model. Micro-CT scans of the rats' femurs showed that bone mass decreased similarly in CBD-treated and untreated groups, challenging previous assumptions about CBD's bone-protective capabilities. While the treatment was well-tolerated, the study concluded that cannabidiol should not be considered a standalone therapy for postmenopausal bone loss. Importantly, the research provides valuable insights into CBD's limitations in bone metabolism, suggesting that more targeted approaches may be necessary for addressing osteoporosis.

💡 Key Findings

CBD did not prevent bone density decline in ovariectomized rat model

High

85%

No significant protective effects observed in bone metabolism markers

Good

75%

Cannabidiol treatment was well-tolerated with no adverse effects

High

90%

📄 Original Abstract

Cannabidiol (CBD) effects on bone metabolism in postmenopausal osteoporosis remain unclear. While endocannabinoids and phytocannabinoids bind to receptors in bone cells, direct evidence of CBD's bone-protective effects is lacking. We evaluated the effects of CBD on bone metabolism in ovariectomized (OVX) rat model of estrogen deficiency. Twelve-week study with treatment initiated 2 wk after the surgery was conducted. Five experimental groups were established: sham-operated with vehicle (SHM/VEH), sham with CBD (SHM/CBD5), OVX with vehicle (OVX/VEH), OVX with 17β-estradiol (OVX/E2), and OVX with CBD (OVX/CBD5). Cannabidiol was administered at 5 mg/kg/d via osmotic pumps. Micro-CT of the distal femur revealed that trabecular bone mass in OVX/CBD5 decreased similarly to OVX/VEH, indicating no protective effect. Serum bone turnover markers showed increased bone resorption in OVX/CBD5 compared to OVX/VEH. Gene expression analysis revealed that estrogen significantly reduced Ctsk gene expression compared to OVX/VEH, while CBD showed no significant differences. No significant changes were observed in cannabinoid receptor expression or bone metabolism in sham-operated rats receiving CBD. While CBD (5 mg/kg/d) was well-tolerated, it did not mitigate OVX-induced bone loss in skeletally mature rats. Consequently, CBD should not be considered a monotherapy for postmenopausal osteoporosis, though it appears safe for other potential medical applications.

Paper Type

📄 Research

Publication

Journal: JBMR plus
Published: February 1, 2026
PMID: 41589111
DOI: 10.1093/jbmrpl/ziaf197

Authors (7)

Krittikan Chanpaisaeng Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
James C Fleet Department of Nutritional Sciences, University of Texas, Austin, TX 78712, United States.
Visut Rawiwet Central Animal Facility, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Natthaporn Phonsatta Food Biotechnology Research Team, National Center for Genetic Engineering and Biotechnology, Pathum Thani 12120, Thailand.
Atikorn Panya Food Biotechnology Research Team, National Center for Genetic Engineering and Biotechnology, Pathum Thani 12120, Thailand.
+2 more authors